Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
triptorelin acetate + hCG
- Development stage
- Unknown
- Lead developer
- Debiopharm
- Modality
- Peptides, Small Molecules
- Administration
- Subcutaneous, Intramuscular
01
Overview
Triptorelin acetate + hCG is a combination regimen used primarily as a "dual trigger" for final oocyte maturation in assisted reproductive technology (ART) cycles, such as in vitro fertilization (IVF). Triptorelin acetate is a synthetic gonadotropin-releasing hormone (GnRH) agonist that initially stimulates the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), but with continued use suppresses their secretion. Human chorionic gonadotropin (hCG) acts as an LH analog, directly stimulating final oocyte maturation and ovulation. The dual trigger approach aims to optimize oocyte quality and reduce the risk of ovarian hyperstimulation syndrome (OHSS), especially in high ovarian responders undergoing GnRH antagonist protocols[1][2]. This combination does not negatively impact embryo quality or pregnancy rates compared to hCG alone, but significantly lowers the incidence of OHSS[2].
- Brand names
- OvitrelleDecapeptyl
- Other names
- dual trigger (triptorelin acetate + hCG)
02
Targets
LHCGR (Luteinizing hormone/choriogonadotropin receptor)GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on triptorelin acetate + hCG.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on triptorelin acetate + hCG.